{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018877","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2025-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.558526+00:00","generated_at":"2026-05-17T02:55:21.188818+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"CEO Vuong Trieu presented at LD Micro conference on Oct 21; specifics not disclosed in filing","bullets":["CEO Vuong Trieu presented a corporate presentation at LD Micro in San Diego on October 21, 2025.","Exhibit 99.1 containing the presentation is attached but its content was not reproduced in this filing.","No financial results, clinical updates, or guidance changes were provided in the 8-K text.","This is a procedural 8.01 announcement of an investor presentation; no material operational detail."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018877","json":"https://secwatch.observer/filing/0001493152-25-018877.json","markdown":"https://secwatch.observer/filing/0001493152-25-018877.md","text":"https://secwatch.observer/filing/0001493152-25-018877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315225018877/0001493152-25-018877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315225018877/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:55:21.188818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}